GoHealth, Inc. 8-K

What Happened
GoHealth, Inc. (Nasdaq: GOCO) announced in an 8‑K filed March 20, 2026 that on March 18, 2026 it received a written notice from Nasdaq saying the company is not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires a minimum market value of listed securities (MVLS) of $35 million. Nasdaq also indicated GoHealth does not meet the alternative continued‑listing tests for stockholders’ equity ($2.5 million) or net income from continuing operations ($500,000). The notice does not affect current trading — GOCO will continue to trade on The Nasdaq Global Market — and the company has a 180‑day compliance period to regain the MVLS requirement.

Key Details

• Notice date: March 18, 2026; Form 8‑K filed March 20, 2026.
• MVLS requirement: $35.0 million under Nasdaq Listing Rule 5550(b)(2).
• Compliance period: 180 calendar days, ending September 14, 2026.
• Regain standard: market value must close at $35M+ for at least 10 consecutive business days (Nasdaq may require up to ~20).
• If compliance is not regained, Nasdaq is expected to issue a delisting notice; the company can appeal to a Nasdaq Hearings Panel, which would stay any delisting pending the hearing.

Why It Matters
This notice signals a material listing risk: if GoHealth does not restore its market value (or otherwise meet Nasdaq’s alternative standards) within the 180‑day window, its shares could be subject to delisting proceedings. For investors, the immediate impact is limited — GOCO continues to trade — but there is increased execution and liquidity risk if delisting occurs, and potential share‑price pressure during the compliance period. The company said it is evaluating options to regain compliance but gave no assurance it will succeed.